Telink Pharmaceutical (01011.HK) rose by 250%. The company announced that it is considering issuing letter shares to four creditors to capitalize the outstanding principal amount and interest of the existing loans owed by the group to subscribers.
泰凌医药(01011.HK)开涨250%,公司公告考虑向四名债权人发行信股份以将集团结欠认购人现有贷款未偿还本金额及利息资本化。